// App-Quantinova.ai

THU0392 : PATIENT JOURNEY TO DIAGNOSIS OF ANKYLOSING SPONDYLITIS AND ITS TREATMENT PATTERNS ACROSS CENTRAL EASTERN EUROPE AND THE UNITED STATES

Researchers

Presenter

  • T. Korotaeva

Principal Investigators

  • O. Dina

  • E. Holdsworth

  • L. Fallon

  • G. Milligan

  • S. Meakin

  • L. Wang

  • R. S. Vasilescu

  • J. C. Cappelleri

  • A. Deodhar

Medical Centers

  • VA Nasonova Institute of Rheumatology, Moscow, Russian Federation, Moscow, Russia

  • Pfizer, Inc, New York, NY, United States of America

  • Adelphi Real World, Bollington, United Kingdom

  • Pfizer Canada, Montreal, QC, Canada

  • Pfizer, Inc, Groton, CT, United States of America

  • Pfizer, Brussels, Belgium

  • Oregon Health & Science University, Portland, United States of America

Locations

  • Russia

  • United States

  • United Kingdom

  • Canada

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

  • Autoimmune (AI)

Disease

  • Non-radiographic axial spondyloarthritis

  • Ankylosing spondylitis

  • Spondyloarthritis

  • Sacroiliitis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Pfizer

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved